Following the recall by Sanofi for over-the-counter Zantac because it may contain a cancer-causing ingredient, another company has issued recalls for heartburn medication.

Dr. Reddy’s Laboratories (RDY) has recalled both over-the-counter and prescription ranitidine medication sold in the U.S. because it may contain N-Nitrosodimethylamine (NDMA), a known human carcinogen, above the levels established by the U.S. Food and Drug Administration (FDA).

The recall affects all quantities of the ranitidine, including medications sold at retailers such as Sam’s Club, Walgreens, Walmart, Kroger, CVS, and Target. The recalled heartburn medication can be identified by the NDC numbers on the product label. The medication has an expiration date of September 2019 to June 2021.

A full list of recalled ranitidine medications can be viewed here. Labels of the recalled medication can be viewed here.

Questions about the recall can be directed to Dr. Reddy’s Medical Information Call Center at 1-888-375-3784 (1-888-DRL-DRUG) Monday through Friday from 8 a.m. to 8 p.m. ET.

Over-the-counter ranitidine is used to treat heartburn associated with acid indigestion and sour stomach caused by eating or drinking certain foods and beverages. Prescription ranitidine is used for short-term treatment of active duodenal ulcers, active, benign gastric ulcers, gastroesophageal reflux disease (GERD), and erosive esophagitis, as well as pathological hypersecretory conditions such as Zollinger-Ellison syndrome and systemic mastocytosis.

The company has not received any reports of adverse effects from the recalled medication. Individuals that experience problems related to the recalled medication should contact their healthcare provider.

Shares of Dr. Reddy's Laboratories stock were down 1.32 percent as of 11:05 a.m. ET on Thursday.

There are a number of natural ways to treat indigestion. Shutterstock